The MC38 s.c. injection model allows us to assess engraftment and growth of established colon cancer cells, yet it does not allow us to study the role of GPR4 in early tumor development, which in the case of CRC can be driven by inflammation. Here, GPR4 is linked to malignant colon neoplasm.